Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development

dc.contributor.authorSaidemberg, D. M. [UNESP]
dc.contributor.authorPassarelli, A. W. [UNESP]
dc.contributor.authorRodrigues, A. V. [UNESP]
dc.contributor.authorBasso, L. A.
dc.contributor.authorSantos, D. S.
dc.contributor.authorPalma, Mario Sergio [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionNatl Inst Sci & Technol Immunol INCT III
dc.contributor.institutionPontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
dc.contributor.institutionNatl Inst Sci & Technol TB INCT TB
dc.date.accessioned2014-05-20T13:55:18Z
dc.date.available2014-05-20T13:55:18Z
dc.date.issued2011-03-01
dc.description.abstractThe enzymes of the shikimate pathway represent potential molecular targets for the development of non-toxic antimicrobial agents and anti-parasite drugs. One of the most promising of these enzymes is shikimate kinase (EC 2.7.1.71), which is responsible for the fifth step in the shikimate pathway. This enzyme phosphorylates shikimic acid to yield shikimate-3-phosphate, using ATP as a substrate. In this work, the conformational dynamics of the shikimate kinase from Mycobacterium tuberculosis was investigated in its apostate in solution. For this study, the enzyme was subjected to a gradient of temperatures from 15 degrees C to 45 degrees C in the presence or absence of deuterium oxide, and the amide H/D exchange was monitored using ESI-mass spectrometry. We observed: i) the phosphate binding domain in the apo-enzyme is fairly rigid and largely protected from solvent access, even at relatively high temperatures; ii) the shikimate binding domain is highly flexible, as indicated by the tendency of the apo-enzyme to exhibit large conformational changes to permit LID closure after the shikimate binding; iii) the nucleotide binding domain is initially conformationally rigid, which seems to favour the initial orientation of ADP/ATP, but becomes highly flexible at temperatures above 30 degrees C, which may permit domain rotation; iv) part of the LID domain, including the phosphate binding site, is partially rigid, while another part is highly flexible and accessible to the solvent.en
dc.description.affiliationSão Paulo State Univ UNESP, CEIS, Dept Biol, Inst Biosci Rio Claro, BR-13506900 Rio Claro, SP, Brazil
dc.description.affiliationNatl Inst Sci & Technol Immunol INCT III, Alegre, RS, Brazil
dc.description.affiliationPontifical Catholic Univ Rio Grande Sul PUCRS, Ctr Res Mol & Funct Biol, Porto Alegre, RS, Brazil
dc.description.affiliationNatl Inst Sci & Technol TB INCT TB, Alegre, RS, Brazil
dc.description.affiliationUnespSão Paulo State Univ UNESP, CEIS, Dept Biol, Inst Biosci Rio Claro, BR-13506900 Rio Claro, SP, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipINCT-TB
dc.description.sponsorshipFinanciadora de Estudos e Projetos (FINEP)
dc.description.sponsorshipIdFAPESP: 06/57122-7
dc.format.extent1299-1310
dc.identifierhttp://dx.doi.org/10.2174/092986711795029500
dc.identifier.citationCurrent Medicinal Chemistry. Sharjah: Bentham Science Publ Ltd, v. 18, n. 9, p. 1299-1310, 2011.
dc.identifier.doi10.2174/092986711795029500
dc.identifier.issn0929-8673
dc.identifier.lattes2901888624506535
dc.identifier.urihttp://hdl.handle.net/11449/19787
dc.identifier.wosWOS:000288986300005
dc.language.isoeng
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofCurrent Medicinal Chemistry
dc.relation.ispartofjcr3.469
dc.relation.ispartofsjr1,015
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectTuberculosisen
dc.subjectdrug developmenten
dc.subjectshikimate kinaseen
dc.subjectmass spectrometryen
dc.subjectH/D exchangeen
dc.titleShikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Developmenten
dc.typeResenha
dcterms.licensehttp://www.benthamscience.com/permission.php
dcterms.rightsHolderBentham Science Publ Ltd
unesp.author.lattes2901888624506535
unesp.author.orcid0000-0002-7363-8211[6]
unesp.author.orcid0000-0003-0903-2407[4]
unesp.campusUniversidade Estadual Paulista (Unesp), Instituto de Biociências, Rio Claropt

Arquivos

Licença do Pacote
Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: